Martínez-Bosch, N., & Neoptolemos, J. P. (2018). Increased plasma levels of galectin-1 in pancreatic cancer: Potential use as biomarker. OncoTarget, 9(68), . https://doi.org/10.18632/oncotarget.26034
Chicago Style (17th ed.) CitationMartínez-Bosch, Neus, and John P. Neoptolemos. "Increased Plasma Levels of Galectin-1 in Pancreatic Cancer: Potential Use as Biomarker." OncoTarget 9, no. 68 (2018). https://doi.org/10.18632/oncotarget.26034.
MLA (9th ed.) CitationMartínez-Bosch, Neus, and John P. Neoptolemos. "Increased Plasma Levels of Galectin-1 in Pancreatic Cancer: Potential Use as Biomarker." OncoTarget, vol. 9, no. 68, 2018, https://doi.org/10.18632/oncotarget.26034.
Warning: These citations may not always be 100% accurate.